How Long Does It Take to Get Approved for Wegovy?

The decision that matters most: NHS or private?

The single biggest factor in your approval timeline is which route you choose. These two pathways operate on completely different timescales, and understanding why will save you weeks of confusion.

On the NHS, Wegovy is available through specialist weight management services under NICE Technology Appraisal 875, which recommends it alongside a multidisciplinary programme. Getting there involves a GP referral, a triage process, and then joining a service with its own waiting list. In many parts of England that combined wait is measured in months, not weeks. Wales, Scotland and Northern Ireland run their own access criteria and referral systems, so availability varies further still.

Private prescription services work differently. A prescriber reviews your consultation directly and, if you meet the clinical criteria, can approve the same day. At nume, a GPhC-registered Independent Prescriber reads every submission personally. There is no algorithm making the decision. Once approved and dispatched, your treatment arrives via DPD the next working day, in plain unbranded packaging, with tracking on your phone. For many people who don't meet the current NHS criteria, or who simply can't wait, this is what access to Wegovy practically looks like. You can read more about the different routes to getting Wegovy if you want a full comparison before deciding.

The right route depends on your eligibility, your circumstances, and how urgently treatment matters to your health. Neither option should be rushed into; both require genuine clinical assessment.

What the prescriber is actually checking during approval

Whichever route you take, approval is not a formality. A prescriber is making a clinical decision, and the time that takes reflects how much is involved.

They are checking BMI against the licensed thresholds (BMI 30 or above, or 27 to 29.9 with at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea), as the NHS semaglutide medicines page and the SmPC both set out. They are also reviewing your medical history for contraindications, including any history of pancreatitis, medullary thyroid carcinoma or MEN2 syndrome. Current medicines are checked for potential interactions. Pregnancy, breastfeeding, or trying to conceive will mean Wegovy is not recommended.

At a private service with robust safety infrastructure, this review should also involve identity verification and, in some cases, live weight verification on video, to ensure the clinical picture matches what was submitted. If you are transferring from another provider or requesting a dose increase, evidence of your current treatment and weight history matters too. The Wegovy treatment page sets out the full eligibility picture if you want to check where you stand before starting a consultation. None of this makes the process slow for its own sake; it makes approval meaningful.

Timeline factors you can influence

Once you understand what drives the timeline, some of it is within your control.

Submitting a complete, accurate consultation is the most important thing. Gaps in your medical history, uncertainty about your current medicines, or an unclear weight record can all prompt follow-up, which adds time. Ordering before 12pm on a working day matters if same-day dispatch is important to you. If you're considering the private route, it's also worth reading about what to expect as your body adjusts to Wegovy in those first weeks, because the adjustment period is a separate timeline from the approval one, and knowing it in advance helps you plan.

On the cost side, private Wegovy treatment is priced per prescription and varies by dose; if that's a consideration, the Wegovy cost page explains what UK private pricing typically covers and what to watch out for. There's a meaningful difference between a price that includes clinical review, prescription, delivery and aftercare and a headline figure that doesn't. Worth knowing before you commit. One useful marker: the quality of the service you're dealing with is often clearest when something goes wrong or a question arises, not at the point of ordering.

If your timeline is driven by the NHS route, the most useful step is speaking to your GP about a referral. Be specific about your weight-related conditions; referral criteria are tied to them. You can also look at the weight-loss treatments overview for context on how the different approved options compare.

After approval: what the first weeks actually look like

Approval is the beginning, not the destination. Understanding the titration schedule helps set realistic expectations for what comes next.

Wegovy starts at 0.25 mg weekly, a dose designed to let your body adjust rather than to produce noticeable weight change immediately. The prescriber then guides you through increases, typically every four weeks, towards the 2.4 mg maintenance dose (or the recently approved 7.2 mg for those who qualify). Most people do not experience significant weight loss in the first four weeks; clinical trial data in STEP 1 showed meaningful average reductions over 68 weeks at the maintenance dose. Appetite suppression tends to become noticeable a few weeks in, and the gastrointestinal side effects that some people experience (nausea, loose stools, reflux) are most common early and often settle as the dose stabilises.

Questions about how long Wegovy takes to produce results are closely related to this titration timeline; the short answer is that the maintenance dose, not the starting one, is where the main evidence sits. For a fuller picture of what STEP 1 and the 7.2 mg trial data actually showed, the Wegovy weight loss timeline page goes through it in detail. And if you're still weighing up whether Wegovy or another licensed option fits your situation better, the free consultation is the practical next step: a real prescriber, your specific circumstances, no obligation to proceed.